71 related articles for article (PubMed ID: 17687254)
1. Clinical studies of hemodialysis access through formaldehyde-fixed arterial allografts.
Liu Z; Zhu B; Wang X; Jing Y; Wang P; Wang S; Xu H
Kidney Int; 2007 Nov; 72(10):1249-54. PubMed ID: 17687254
[TBL] [Abstract][Full Text] [Related]
2. Reduced antigenicity of formaldehyde-fixed arterial allografts and their potential clinical application.
Liu Z; Zhu B; Wang X; Jing Y; Wang P; Xu H
Transplant Proc; 2008 Oct; 40(8):2750-4. PubMed ID: 18929853
[TBL] [Abstract][Full Text] [Related]
3. Formaldehyde-fixed arterial allograft as a novel vascular access alternative in end-stage renal disease patients.
Canaud B
Kidney Int; 2007 Nov; 72(10):1179-81. PubMed ID: 17972906
[TBL] [Abstract][Full Text] [Related]
4. Utility of formaldehyde-fixed arterial allografts for hemodialysis access.
Roy-Chaudhury P
Nat Clin Pract Nephrol; 2008 Feb; 4(2):74-5. PubMed ID: 18030292
[No Abstract] [Full Text] [Related]
5. Clinical Outcomes of Cryopreserved Arterial Allograft Used as a Vascular Conduit for Hemodialysis.
Ha TY; Kim YH; Chang JW; Park Y; Han Y; Kwon H; Kwon TW; Han DJ; Cho YP; Lee SG
J Korean Med Sci; 2016 Aug; 31(8):1266-72. PubMed ID: 27478338
[TBL] [Abstract][Full Text] [Related]
6. Selection of hemodialysis versus cadaveric transplantation.
Kreis H
Kidney Int Suppl; 1978 Jun; (8):S91-4. PubMed ID: 357819
[TBL] [Abstract][Full Text] [Related]
7. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
[TBL] [Abstract][Full Text] [Related]
8. Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients.
Fuster V; Charlton P; Boyd A
Hum Gene Ther; 2001 Nov; 12(16):2025-7. PubMed ID: 11727735
[TBL] [Abstract][Full Text] [Related]
9. Identification of platelet-derived growth factor A and B chains in human renal vascular rejection.
Alpers CE; Davis CL; Barr D; Marsh CL; Hudkins KL
Am J Pathol; 1996 Feb; 148(2):439-51. PubMed ID: 8579107
[TBL] [Abstract][Full Text] [Related]
10. Decellularized cadaver vein allografts used for hemodialysis access do not cause allosensitization or preclude kidney transplantation.
Madden R; Lipkowitz G; Benedetto B; Kurbanov A; Miller M; Bow L
Am J Kidney Dis; 2002 Dec; 40(6):1240-3. PubMed ID: 12460043
[TBL] [Abstract][Full Text] [Related]
11. Expected flow parameters within hemodialysis access and selection for remedial intervention of nonmaturing conduits.
Back MR; Maynard M; Winkler A; Bandyk DF
Vasc Endovascular Surg; 2008; 42(2):150-8. PubMed ID: 18276776
[TBL] [Abstract][Full Text] [Related]
12. Laser microdissection and gene expression analysis on formaldehyde-fixed archival tissue.
Cohen CD; Gröne HJ; Gröne EF; Nelson PJ; Schlöndorff D; Kretzler M
Kidney Int; 2002 Jan; 61(1):125-32. PubMed ID: 11786092
[TBL] [Abstract][Full Text] [Related]
13. [Formation of a vascular access in patients with terminal chronic renal insufficiency for hemodialysis based on the new general theory of circulation].
Egin AA; Shabanov VI; Chukhrienko ST; Koshev VI; Petrov ES
Angiol Sosud Khir; 2003; 9(4):119-21. PubMed ID: 14657921
[TBL] [Abstract][Full Text] [Related]
14. Aortoiliac reconstruction with allograft and kidney transplantation as a one-stage procedure: long term results.
Matia I; Adamec M; Varga M; Janousek L; Lipar K; Viklicky O
Eur J Vasc Endovasc Surg; 2008 Mar; 35(3):353-7. PubMed ID: 18065247
[TBL] [Abstract][Full Text] [Related]
15. Increased mRNA expression of transforming growth factor beta in the arterial wall of chronically rejected renal allografts in humans.
Zegarska J; Paczek L; Pawlowska M; Wyczalkowska A; Michalska W; Ziolkowski J; Gorski A; Rowinski W; Kosieradzki M; Kwiatkowski A; Gornicka B; Ziarkiewicz-Wroblewska B
Transplant Proc; 2006; 38(1):115-8. PubMed ID: 16504679
[TBL] [Abstract][Full Text] [Related]
16. A randomized multicenter study of the outcome of brachial-basilic arteriovenous fistula and prosthetic brachial-antecubital forearm loop as vascular access for hemodialysis.
Keuter XH; De Smet AA; Kessels AG; van der Sande FM; Welten RJ; Tordoir JH
J Vasc Surg; 2008 Feb; 47(2):395-401. PubMed ID: 18155872
[TBL] [Abstract][Full Text] [Related]
17. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
18. An Outcomes Comparison of Native Arteriovenous Fistulae, Polytetrafluorethylene Grafts, and Cryopreserved Vein Allografts.
Jadlowiec CC; Lavallee M; Mannion EM; Brown MG
Ann Vasc Surg; 2015 Nov; 29(8):1642-7. PubMed ID: 26319146
[TBL] [Abstract][Full Text] [Related]
19. Cryopreserved arterial allograft reconstruction for peripheral graft infection.
Castier Y; Francis F; Cerceau P; Besnard M; Albertin J; Fouilhe L; Cerceau O; Albaladejo P; Lesèche G
J Vasc Surg; 2005 Jan; 41(1):30-7. PubMed ID: 15696040
[TBL] [Abstract][Full Text] [Related]
20. Reduced antibody response in patients with chronic renal failure undergoing hemodialysis with formaldehyde sterilized units.
Sharon R
Transfusion; 1979; 19(6):754-5. PubMed ID: 574997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
